Back to BAILLIE GIFFORD & CO

RPRX
Showing 8 of 17 quarters

Position history for BAILLIE GIFFORD & CO's holdings in ROYALTY PHARMA PLC

BAILLIE GIFFORD & CO holds 16.2M shares of RPRX (ROYALTY PHARMA PLC), worth $775M as of 2026-Q1. The position was decreased (-5.0% shares). RPRX represents 0.8% of BAILLIE GIFFORD & CO's portfolio.

Current Value

$775M

Current Shares

16.2M

Total Value Change

+$343.8M

Total Shares Change

-197,082

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
16.2M
-5.0%
$775M0.8%$47.48
0
2025-Q4
Decreased
17M
-2.1%
$657.2M0.5%$38.99
0
2025-Q3
Decreased
17.4M
-3.6%
$612.9M0.5%$35.05
0
2025-Q2
Increased
18M
+34.5%
$649.3M0.5%$35.46
49
2025-Q1
Decreased
13.4M
-5.2%
$417.2M0.4%$30.80
0
2024-Q4
Decreased
14.1M
-12.3%
$360.6M0.3%$24.70
0
2024-Q3
Decreased
16.1M
-1.4%
$456.1M0.3%$27.29
0
2024-Q2
Decreased
16.4M
-1.9%
$431.2M0.3%$25.32
0

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used